Related Experiment Video
Updated: Feb 27, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study
Jan K Nowak1, Irena Wojsyk-Banaszak2, Edyta Mądry3
1Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Insights
Cystic fibrosis (CF) patients have higher levels of soluble vascular cell adhesion molecule 1 (sVCAM-1) compared to healthy individuals. These elevated sVCAM-1 levels in CF are not explained by common CF characteristics, suggesting a potential link to cardiovascular health.
Area of Science:
- Cardiovascular Health
- Pulmonary Medicine
- Biomarker Discovery
Background:
- Increasing life expectancy in cystic fibrosis (CF) necessitates understanding its long-term impacts, including cardiovascular health.
- Soluble vascular cell adhesion molecule 1 (sVCAM-1) and P-selectin (sP-selectin) are investigated as potential biomarkers for cardiovascular disease.
- The study addresses the emerging questions about cardiovascular implications in the growing CF population.
Purpose of the Study:
- To compare serum concentrations of sVCAM-1 and sP-selectin in clinically stable CF patients versus healthy subjects (HS).
- To determine if sVCAM-1 and sP-selectin levels independently correlate with specific CF characteristics.
- To investigate potential cardiovascular disease biomarkers in the context of CF.
Main Methods:
- Serum sVCAM-1 and sP-selectin levels were quantified using enzyme-linked immunosorbent assay (ELISA).
- CF patient characteristics included lung function (FEV1), pancreatic and liver disease status, Pseudomonas aeruginosa colonization, hsCRP, and BMI.
- CFTR genotypes were categorized as severe (classes I/II) or other.
Main Results:
- CF patients (n=108) exhibited significantly higher sVCAM-1 concentrations than HS (n=51) (p < 10⁻⁴).
- No significant difference was observed in sP-selectin levels between CF patients and HS (p = 0.48).
- Multivariable regression models could not validate the prediction of sVCAM-1 or sP-selectin based on CF characteristics.
Conclusions:
- Elevated sVCAM-1 levels are present in CF patients compared to healthy individuals.
- The observed increase in sVCAM-1 in CF is not attributable to known CF-related clinical parameters.
- Further investigation is warranted to ascertain if sVCAM-1 serves as a marker for microangiopathy in cystic fibrosis.
Purpose:
As life expectancy in cystic fibrosis (CF) increases, questions regarding its potential impact on cardiovascular health arise. Soluble vascular cell adhesion molecule 1 (sVCAM-1), P-selectin (sP-selectin) are proposed as biomarkers of cardiovascular disease. We aimed to: compare their concentrations in clinically stable CF patients and healthy subjects (HS) and verify whether they independently correlate with CF characteristics.
Methods:
Serum sVCAM-1 and sP-selectin levels were measured using ELISA. CF was characterized using: forced expiratory volume in 1 s, exocrine pancreatic and CF-related liver disease status, Pseudomonas aeruginosa colonization, serum high-sensitivity C-reactive protein, and body mass index (BMI). CFTR genotypes were classified as severe (classes I and II) or other.
Results:
108 CF patients and 51 healthy subjects volunteered for the study. In the CF group BMI was lower (median [IQR]: 20.5 kg/m2 [18.4-22.2] vs. 21.6 kg/m2 [19.9-23.4], p = 0.02) and hsCRP levels were higher (3.6 mg/L [1.1-7.1] vs. 0.5 mg/dL [0.3-1.0], p < 10-10). While sVCAM-1 concentrations were greater in CF patients (1018 ng/mL [851-1279] vs. 861 ng/mL [806-979], p < 10-4), sP-selectin levels did not differ (155 ng/mL [129-188] vs. 156 ng/mL [144-177], p = 0.48). None of the multivariable regression models was valid for the prediction of sVCAM-1 and sP-selectin in CF.
Conclusions:
We found higher sVCAM-1 concentrations in CF patients than in healthy subjects, which were not explained by CF characteristics. Further research is required to check whether sVCAM-1 is a marker of microangiopathy in CF.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Selectins
Cystic Fibrosis: Management
Sinus disease and chronic...

